Beyond Type 1: Focus on Access

Millions around the world with Type 1 struggle with issues of access, whether that be for economic, geographic or political reasons. Beyond Type 1 is committed to providing direct efforts and support for partners focused on issues of access, including access to basic supplies and life-saving medication, technology, devices and healthcare to optimize health, personal accounts and breaking news on global access issues and a wide variety of resources.

Life as a Refugee with Type 1 Diabetes

Life with Type 1 is full of ups and downs – and the stress of everyday life can test our ability to manage this chronic illness. Now imagine managing the disease in a war-torn country, or fleeing a conflict and facing new kinds of persecution as you seek refuge.

US Healthcare System Glossary

The US healthcare system is complex; this glossary clarifies some of the terms that most apply to someone living with Type 1 diabetes.

The Latest on COVID-19 From Dr. Anne Peters

Dr. Anne Peters took time to check in about COVID-19 and give us her latest updates, especially pertaining to diabetes care as this situation is unfolding.

Suddenly Jobless or Without Health Insurance? Start Here.

If you've just lost your health insurance coverage or are struggling to afford your medications and supplies, start here.

What to do If You Need Insulin Right Now

If you need insulin immediately but are not sure how you’re going to get it, there are multiple ways to access the insulin you need to keep yourself alive.

Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19

On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.

Insulin Access in a Pandemic: An Interview with Wade Neucks of Lilly Diabetes

Beyond Type 1 chatted with Wade Neucks of Lilly Diabetes about expectations of insulin access in the midst of the COVID-19 pandemic.

Get Help From Home: What Coronavirus Can Teach Us About Telehealth

Telehealth is an untapped resource that could prove helpful in lightening the load when it comes to providing necessary healthcare in the midst of COVID-19 and beyond.

New Insulin Approval Pathway Could Increase Competition

The new regulatory pathway “is expected to increase patient access, adding more choices and potentially reducing costs of these vital therapies.”

Insulin Copay Cap Bills: An Overview

Insulin copayment bills have been a hot topic of conversation in the fight to give Americans with diabetes better access to the drug they need to survive.

COVID-19 Diabetes Supply Chain Updates

Here, you'll find continuous updates on the status of the diabetes supply chain, with up to date information from all major insulin and device manufacturers as it relates to COVID-19.

The Power in Numbers: Change.org’s Affordable Insulin For All Movement

As insulin prices continue to increase in the United States, Change.org is equipping those affected with the tools to speak out.

New Medicare Plan Will Cap Insulin Copays at $35

On March 11, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin.

JDRF CEO to Health Insurers: Cover New Technology

JDRF President & CEO Aaron Kowalski, Ph.D calls on insurers to cover FDA approved type 1 diabetes technology